方正電機(002196.SZ):5名董事、高管減持到期 僅時任高管祝軻卿減持9.625萬股
格隆匯2月14日丨方正電機(002196.SZ)公佈,根據公司收到的《關於股份減持計劃實施完成的吿知函》及公司通過中國證券登記結算有限責任公司深圳分公司系統查詢獲悉,截至2023年2月14日,公司董事長馮融,副董事長鄒建生,董事、財務總監徐華月,董事何德軍,時任高管祝軻卿披露的減持計劃已完成。
其中,祝軻卿於2022年8月11日-8月18日通過集中競價方式累計減持公司股份9.625萬股,佔公司總股本的0.0193%;而馮融、鄒建生、徐華月、何德軍均未減持公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.